EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Presented by

Synopsis

The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the product of a joint effort by the European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO). They update a position statement based on the 2009 EASL Special Conference.

Keywords: placebo-controlled trial; randomized controlled trial; hepatic insulin resistance; cardiometabolic risk factors; type-2 diabetic subjects; lifestyle intervention; vitamin E; cardiovascular disease; stiffness measurement; weight loss

Available Languages

English

Source File

Publishing organization(s):

European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)

Scientific area:

Hepatobiliary
  


This item can be cited as: J Hepatol. 2016 Mar 10; PMID 27062661

Categorisation:

  • Format
    • Standards and Guidelines
  • Language
    • English
  • UEG Member Society
    • European Association for the Study of the Liver (EASL)
  • UEG Week Pathway
    • Hepatobiliary
  • Year
    • 2016